# 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery

> **NCT01455233** · PHASE4 · COMPLETED · sponsor: **Ophthalmology Consultants, Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Corneal Health
- Cataract Surgery

## Interventions

- **DRUG:** besivance
- **DRUG:** vigamox

## Key facts

- **NCT ID:** NCT01455233
- **Lead sponsor:** Ophthalmology Consultants, Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455233, "2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01455233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*